A Symmetrical Dirhenium(I) Complex with 4,4’’-Azobis(2,2’-bipyridine) as a Bridging Ligand: Synthesis, Physicochemical Properties and Applications in Detection of Biologically Relevant Thiols and in Chemotherapy for Bone Cancer

A new dinuclear complex of formula [{Re(CO)₃(py)}₂(μ-4,4”-azobpy)](PF₆)₂, with py = pyridine and 4,4”-azobpy = 4,4”-azobis(2,2’-bipyridine), has been synthesized and characterized by spectroscopic and electrochemical techniques. The symmetrical nature of the dimetallic cation has been confirmed by n...

Descripción completa

Detalles Bibliográficos
Autores: Abate, Pedro Oscar, Sottile, Marco, León, Ignacio Esteban, Vergara, Mónica M., Katz, Néstor E.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:Argentina
Institución:Universidad Nacional de La Plata
Repositorio:SEDICI (UNLP)
Idioma:inglés
OAI Identifier:oai:sedici.unlp.edu.ar:10915/123623
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/123623
Access Level:acceso abierto
Palabra clave:Ciencias Exactas
Química
rhenium
thiol detection
chemotherapy
Descripción
Sumario:A new dinuclear complex of formula [{Re(CO)₃(py)}₂(μ-4,4”-azobpy)](PF₆)₂, with py = pyridine and 4,4”-azobpy = 4,4”-azobis(2,2’-bipyridine), has been synthesized and characterized by spectroscopic and electrochemical techniques. The symmetrical nature of the dimetallic cation has been confirmed by nuclear magnetic resonance (NMR) measurements. When adding L-cysteine or L-glutathione, large and rapid changes in its UV-Vis absorption spectra were observed, which can be used for detecting both biologically relevant thiols. A promising activity for using this complex as a chemotherapeutic agent for bone cancer was also disclosed. Quantum mechanical calculations supported the experimental data.